Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00194688 · ClinicalTrials.gov registry record · Phase 2

Breath Ammonia Method for H. Pylori Detection: Phase II

A Phase 2 study, sponsored by University of Washington.

Completed
Registry status
Phase 2
Development phase
278
Enrollment target

NCT00194688: Completed Phase 2 study, sponsored by University of Washington.

NCT00194688 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 278 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (109% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00194688, a Phase 2 study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
Phase 2
Development phase
278 participants
Enrollment target

Study Summary

The objective is to evaluate the utility of a breath ammonia sensing device. In this study we will assess the effect of H. pylori infection on breath ammonia levels by measuring whether there is a change in the pattern or quantity of breath ammonia seen in H. pylori positive patients compared to H. pylori negative patients.

Interventions

  • DRUG H. pylori treatment

Trial Details

FieldValue
Enrollment Target 278 participants
Start Date 2003-03
Est. Completion 2005-06
Phase Phase 2
University of Washington

1,048 total trials

What the finished NCT00194688 record still lists

NCT00194688 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (109% higher).

The record links to 0 conditions, and to 1 intervention - of which H. pylori treatment is the first listed.

NCT00194688 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00194688 about?

NCT00194688 is a clinical study titled "Breath Ammonia Method for H. Pylori Detection: Phase II". The objective is to evaluate the utility of a breath ammonia sensing device. In this study we will assess the effect of H. pylori infection on breath ammonia levels by measuring whether there is a change in the pattern or quantity of breath ammonia seen in H. pylori positive patients compared to H. ...

What is the current status of trial NCT00194688?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 278 participants. The study started on 2003-03. Estimated completion is 2005-06.

What interventions are being tested in trial NCT00194688?

The interventions under investigation include: H. pylori treatment (DRUG).

Who is sponsoring clinical trial NCT00194688?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00194688's enrollment target sits among peer trials

278 202nd of 2000 higher than 1,799 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04586959 · 278 participants · NA

    Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

  • NCT05010148 · 278 participants · Phase 3

    A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain

  • NCT05489237 · 278 participants · Phase 1

    First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

  • NCT05965245 · 278 participants · NA

    Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00194688, the US trial registry maintained by the National Library of Medicine. NCT00194688 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.